Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation

Data on efficacy and safety of sorafenib in a neoadjuvant setting for HCC awaiting liver transplantation (LT) are heterogeneous and scarce. We aimed to investigate the trajectory of patients treated with sorafenib while awaiting LT. All patients listed for HCC and treated with sorafenib were include...

Descripción completa

Detalles Bibliográficos
Autores principales: Minoux, Kate, Lassailly, Guillaume, Ningarhari, Massih, Lubret, Henri, El Amrani, Medhi, Canva, Valérie, Truant, Stéphanie, Mathurin, Philippe, Louvet, Alexandre, Lebuffe, Gilles, Goria, Odile, Nguyen-Khac, Eric, Boleslawski, Emmanuel, Dharancy, Sebastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681796/
https://www.ncbi.nlm.nih.gov/pubmed/36438781
http://dx.doi.org/10.3389/ti.2022.10569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681796/
https://www.ncbi.nlm.nih.gov/pubmed/36438781
http://dx.doi.org/10.3389/ti.2022.10569

Ejemplares similares